Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Androgenic Vaginal Rings for Diminished Ovarian Reserve
NCT02268032Phase 1Completed
- Sponsor
- Laboratorios Andromaco S.A.
- Start
- Jul 2014
- Primary completion
- Aug 2016
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dehydroepiandrosterone and testosterone in Diminished Ovarian Reserve (DOR) (3 arms), sponsored by Laboratorios Andromaco S.A. Primary endpoint: Effect of the association of DHEA plus testosterone over ovarian reserve markers at 2 months. Started Jul 2014; status: completed.
02
Drugs
dehydroepiandrosteronetestosterone
03
Conditions
Diminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on NCT02268032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02268032.